Global Hereditary Angioedema Drug Market Research Report 2021
Global Hereditary Angioedema Drug Market Research Report 2021
Insights into the Hereditary Angioedema Drug Market include supply chain optimization, Hereditary Angioedema Drug challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Hereditary Angioedema Drug Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Hereditary Angioedema Drug Market Overview:
Global Hereditary Angioedema Drug Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Hereditary Angioedema Drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Hereditary Angioedema Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Hereditary Angioedema Drug market in 2020.
Global Hereditary Angioedema Drug Market Segmentation
By Type, Hereditary Angioedema Drug market has been segmented into:
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
By Application, Hereditary Angioedema Drug market has been segmented into:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Hereditary Angioedema Drug market are:
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
1. Market Overview of Hereditary Angioedema Drug
1.1 Hereditary Angioedema Drug Market Overview
1.1.1 Hereditary Angioedema Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Hereditary Angioedema Drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Hereditary Angioedema Drug Historic Market Size by Regions (2015-2020)
1.4 Hereditary Angioedema Drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Hereditary Angioedema Drug Sales Market by Type (2015-2026)
2.1 Global Hereditary Angioedema Drug Historic Market Size by Type (2015-2020)
2.2 Global Hereditary Angioedema Drug Forecasted Market Size by Type (2021-2026)
2.3 By Product
2.4 C1 Esterase Inhibitor
2.5 Kallikrein Inhibitor
2.6 Selective Bradykinin B2 Receptor Antagonist
2.7 By Route of Administration
2.8 Oral
2.9 Intravenous
2.10 Subcutaneous Injection
3. Covid-19 Impact Hereditary Angioedema Drug Sales Market by Application (2015-2026)
3.1 Global Hereditary Angioedema Drug Historic Market Size by Application (2015-2020)
3.2 Global Hereditary Angioedema Drug Forecasted Market Size by Application (2021-2026)
3.3 Retail Pharmacies
3.4 Hospital Pharmacies
3.5 Online Pharmacies
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Hereditary Angioedema Drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Hereditary Angioedema Drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Hereditary Angioedema Drug Business
5.1 Pharming Group NV
5.1.1 Pharming Group NV Company Profile
5.1.2 Pharming Group NV Hereditary Angioedema Drug Product Specification
5.1.3 Pharming Group NV Hereditary Angioedema Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Shire plc
5.2.1 Shire plc Company Profile
5.2.2 Shire plc Hereditary Angioedema Drug Product Specification
5.2.3 Shire plc Hereditary Angioedema Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 CSL Limited
5.3.1 CSL Limited Company Profile
5.3.2 CSL Limited Hereditary Angioedema Drug Product Specification
5.3.3 CSL Limited Hereditary Angioedema Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 iBio Inc.
5.4.1 iBio Inc. Company Profile
5.4.2 iBio Inc. Hereditary Angioedema Drug Product Specification
5.4.3 iBio Inc. Hereditary Angioedema Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 BioCryst Pharmaceuticals Inc.
5.5.1 BioCryst Pharmaceuticals Inc. Company Profile
5.5.2 BioCryst Pharmaceuticals Inc. Hereditary Angioedema Drug Product Specification
5.5.3 BioCryst Pharmaceuticals Inc. Hereditary Angioedema Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Ionis Pharmaceuticals Inc.
5.6.1 Ionis Pharmaceuticals Inc. Company Profile
5.6.2 Ionis Pharmaceuticals Inc. Hereditary Angioedema Drug Product Specification
5.6.3 Ionis Pharmaceuticals Inc. Hereditary Angioedema Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Hereditary Angioedema Drug Market Size (2015-2026)
6.2 North America Hereditary Angioedema Drug Key Players in North America (2015-2020)
6.3 North America Hereditary Angioedema Drug Market Size by Type (2015-2020)
6.4 North America Hereditary Angioedema Drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Hereditary Angioedema Drug Market Size (2015-2026)
7.2 East Asia Hereditary Angioedema Drug Key Players in North America (2015-2020)
7.3 East Asia Hereditary Angioedema Drug Market Size by Type (2015-2020)
7.4 East Asia Hereditary Angioedema Drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Hereditary Angioedema Drug Market Size (2015-2026)
8.2 Europe Hereditary Angioedema Drug Key Players in North America (2015-2020)
8.3 Europe Hereditary Angioedema Drug Market Size by Type (2015-2020)
8.4 Europe Hereditary Angioedema Drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Hereditary Angioedema Drug Market Size (2015-2026)
9.2 South Asia Hereditary Angioedema Drug Key Players in North America (2015-2020)
9.3 South Asia Hereditary Angioedema Drug Market Size by Type (2015-2020)
9.4 South Asia Hereditary Angioedema Drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Hereditary Angioedema Drug Market Size (2015-2026)
10.2 Southeast Asia Hereditary Angioedema Drug Key Players in North America (2015-2020)
10.3 Southeast Asia Hereditary Angioedema Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Hereditary Angioedema Drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Hereditary Angioedema Drug Market Size (2015-2026)
11.2 Middle East Hereditary Angioedema Drug Key Players in North America (2015-2020)
11.3 Middle East Hereditary Angioedema Drug Market Size by Type (2015-2020)
11.4 Middle East Hereditary Angioedema Drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Hereditary Angioedema Drug Market Size (2015-2026)
12.2 Africa Hereditary Angioedema Drug Key Players in North America (2015-2020)
12.3 Africa Hereditary Angioedema Drug Market Size by Type (2015-2020)
12.4 Africa Hereditary Angioedema Drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Hereditary Angioedema Drug Market Size (2015-2026)
13.2 Oceania Hereditary Angioedema Drug Key Players in North America (2015-2020)
13.3 Oceania Hereditary Angioedema Drug Market Size by Type (2015-2020)
13.4 Oceania Hereditary Angioedema Drug Market Size by Application (2015-2020)
14. South America
14.1 South America Hereditary Angioedema Drug Market Size (2015-2026)
14.2 South America Hereditary Angioedema Drug Key Players in North America (2015-2020)
14.3 South America Hereditary Angioedema Drug Market Size by Type (2015-2020)
14.4 South America Hereditary Angioedema Drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Hereditary Angioedema Drug Market Size (2015-2026)
15.2 Rest of the World Hereditary Angioedema Drug Key Players in North America (2015-2020)
15.3 Rest of the World Hereditary Angioedema Drug Market Size by Type (2015-2020)
15.4 Rest of the World Hereditary Angioedema Drug Market Size by Application (2015-2020)
16 Hereditary Angioedema Drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Hereditary Angioedema Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|